NeuroSense Therapeutics NRSN
NASDAQ NRSN
$2.46 +0.02 (+0.82%)
At close: Oct 23, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Ending Cash Balance (2020 - 2026)

Updated

Analysis

NeuroSense Therapeutics (NRSN) Ending Cash Balance (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 16.91 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.88 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 1.03 Bn
10 NeuroSense Therapeutics 3.08 Mn -1.36 Mn - 231,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 231,000.00
Dec 31, 2025 166,000.00
Jun 30, 2025 666,000.00
Dec 31, 2024 3.38 Mn
Jun 30, 2024 1.21 Mn
Dec 31, 2023 2.64 Mn
Jun 30, 2023 7.09 Mn
Dec 31, 2022 3.54 Mn
Jun 30, 2022 11.06 Mn
Dec 31, 2021 11.06 Mn
Dec 31, 2020 699,000.00
API Access

NeuroSense Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=NRSN&period=max&api_key=YOUR_API_KEY